This chemical is primarily utilized in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of complex molecules, particularly in the synthesis of compounds with potential therapeutic applications. Its unique structure, featuring trifluoromethyl groups and a cyclohexylamino moiety, makes it valuable for creating molecules with specific biological activities. Researchers often employ it in the design and synthesis of enzyme inhibitors, where its structural components can interact with active sites to modulate enzyme function. Additionally, it is explored in the development of novel drug candidates targeting diseases such as cancer, inflammation, and infectious diseases, due to its ability to enhance the pharmacokinetic properties of the resulting compounds.